Infosys Cuts Average Variable Payout To 70% For Q1 On Margin Pressure

- Gold standard Phase 3 ASSERT study supports supplementary filings in the U.S. and EU   - ASSERT study demonstrated efficacy of Bylvay (odevixibat) in pruritus, bile acids and sleep with a low drug-related